Walmart Makes It Easy to Stay Healthy with Convenient Flu Shots, Now Available Nationwide

Walmart Makes It Easy to Stay Healthy with Convenient Flu Shots, Now Available Nationwide

Customers can get vaccinated against both flu and COVID-19 at the same time where they already shop for groceries and household essentials

BENTONVILLE, Ark.–(BUSINESS WIRE)–
Walmart is helping America stay healthy this flu season by making it easier than ever to get flu shots, so we can all do our part to keep our communities safe. Low-cost flu shots are now available in 4,600+ Walmart pharmacies nationwide via walk-up and community flu shot clinics.

The Centers for Disease Control and Prevention (CDC) recommends everyone aged six months and older receive a flu shot each year. Further, the CDC recommends COVID-19 vaccination for everyone aged 12 and older, especially as cases are on the rise. Walmart pharmacies across the country offer both vaccines, and customers can receive a low-cost flu and free COVID-19 vaccine at the same time, if they choose.

“It’s important we don’t let our guard down with our health this fall. Between COVID-19 vaccines and the annual flu shot, we know people may be experiencing ‘vaccine fatigue,’ but these preventive measures have never been more vital to keeping our communities healthy,” Del Sloneker, senior vice president and chief operating officer, Health and Wellness, said. “It’s on all of us to do our part and is just another way we’re making it simple to live better, healthier lives.”

Walmart’s flu shots are administered by certified pharmacists and health care professionals who are trusted members of their communities and understand local health needs. In addition to just being able to walk-in, Walmart also continues to have a variety of initiatives in place to make it easy to get vaccinated while following COVID-19 safety protocols, including hosting flu shot clinics in select markets. These events will make it quick, easy and convenient for customers to get flu shots in stores nationwide.

Walmart is a center of well-being in the communities it serves and has everything busy families need to live better, healthier, lives this flu season. This includes our pharmacists who can answer any medication related questions, COVID-19 tests, prescription and over-the-counter medication, as well as a variety of immunizations, including COVID-19, flu, measles, mumps, rubella (MMR), varicella (chicken pox), HPV, tetanus, whooping cough (TDAP) and more. In addition, we have low-cost grocery items, ranging from immunity boosting foods to soup and comfort foods. Customers with a Walmart+ membership can also get free shipping on store purchases and reduced prices on select prescriptions. Finally, Walmart continues to offer every day low prices on household essentials like cleaning supplies, tissues, thermometers and more, to help keep everyone safe and healthy. To learn more about the flu shots and wellness resources available at your neighborhood Walmart, please visit www.walmart.com/wellnesshub.

About Walmart

Walmart Inc. (NYSE: WMT) helps people around the world save money and live better – anytime and anywhere – in retail stores, online, and through their mobile devices. Each week, approximately 220 million customers and members visit approximately 10,500 stores and clubs under 48 banners in 24 countries and eCommerce websites. With fiscal year 2021 revenue of $559 billion, Walmart employs over 2.3 million associates worldwide. Walmart continues to be a leader in sustainability, corporate philanthropy and employment opportunity. Additional information about Walmart can be found by visiting corporate.walmart.com, on Facebook at facebook.com/walmart and on Twitter at twitter.com/walmart.

Marilee McInnis

1-800-331-0085

KEYWORDS: United States North America Arkansas

INDUSTRY KEYWORDS: Home Goods Pharmaceutical Other Retail Health Supermarket Convenience Store Discount/Variety Retail

MEDIA:

The Coca-Cola Company to Participate in Barclays Global Consumer Staples Conference

The Coca-Cola Company to Participate in Barclays Global Consumer Staples Conference

ATLANTA–(BUSINESS WIRE)–
The Coca-Cola Company today announced that President and Chief Operating Officer Brian Smith and Chief Financial Officer John Murphy will present Sept. 9 at 10 a.m. ET at the Barclays Global Consumer Staples Conference.

The company invites investors to join a webcast of the event at www.coca-colacompany.com/investors. A downloadable file, as well as a transcript, will be available within 24 hours after the event on the company’s website.

About The Coca-Cola Company

The Coca-Cola Company (NYSE: KO) is a total beverage company with products sold in more than 200 countries and territories. Our company’s purpose is to refresh the world and make a difference. We sell multiple billion-dollar brands across several beverage categories worldwide. Our portfolio of sparkling soft drink brands includes Coca-Cola, Sprite and Fanta. Our hydration, sports, coffee and tea brands include Dasani, smartwater, vitaminwater, Topo Chico, Powerade, Costa, Georgia, Gold Peak, Honest and Ayataka. Our nutrition, juice, dairy and plant-based beverage brands include Minute Maid, Simply, innocent, Del Valle, fairlife and AdeS. We’re constantly transforming our portfolio, from reducing sugar in our drinks to bringing innovative new products to market. We seek to positively impact people’s lives, communities and the planet through water replenishment, packaging recycling, sustainable sourcing practices and carbon emissions reductions across our value chain. Together with our bottling partners, we employ more than 700,000 people, helping bring economic opportunity to local communities worldwide. Learn more at www.coca-colacompany.com and follow us on Twitter, Instagram, Facebook and LinkedIn.

Investors and Analysts: Tim Leveridge, [email protected]

Media: Scott Leith, [email protected]

KEYWORDS: United States North America Georgia

INDUSTRY KEYWORDS: Other Consumer Food/Beverage Consumer Retail Specialty

MEDIA:

Logo
Logo

BioLife Plasma Services Opens First All-Electric Plasma Donation Center

BioLife Plasma Services Opens First All-Electric Plasma Donation Center

The new Tukwila, WA center underscores the urgent patient need for plasma while supporting Takeda’s sustainability goal to have zero carbon emissions by 2040

TUKWILA, Wash.–(BUSINESS WIRE)–
BioLife Plasma Services, part of the global biopharmaceutical company Takeda Pharmaceutical Company Limited, today announced the opening of an all-electric plasma donation center in Tukwila, WA. The new center opening is the first in a sustainability initiative to build all-electric plasma donation centers in the United States (U.S.), contributing to the company’s dedication to deliver better health for people and a brighter future for the world by addressing the urgent need for plasma as well as key environmental challenges.

“It is vital we grow and transform our operations responsibly and sustainably with respect for the people and communities that we serve,” said Sanjay Bhana, Head of U.S. BioLife Operations. “This first all-electric center represents our commitment and leadership in sustainability performance and outcomes, both from an environmental standpoint as well as ensuring a steady supply of medicine developed from plasma, a lifeline for thousands of people who are immune-compromised or live with a variety of other complex conditions. Leading by example, we are empowering our employees to go above and beyond to help conserve the world’s natural resources.”

As the demand for medicine developed from plasma increases, BioLife is expanding to help meet the urgent need for plasma donations. The all-electric Tukwila center is part of BioLife’s growing network of more than 150 state-of-the-art plasma donation centers in the U.S., recognized for their world-class donation safety standards. Plasma donations received at BioLife centers are used by Takeda to make established therapies that treat a range of rare and complex conditions, such as immunodeficiency disorders, for which there are often no alternative treatments.

The commitment to build all-electric plasma donation centers is part of Takeda’s dedication to making environmental stewardship and resource conservation central to its business operations and practices. This is one of several dedicated programs to continue to reduce the company’s environmental footprint. BioLife Plasma Services is a key contributor to Takeda’s pledge to have zero carbon emissions resulting from its own operations by 2040, zero waste to landfill from its major locations by 2030 and a 5% reduction in water use by 2025. More specifically, BioLife will be addressing key environmental concerns through efforts that involve on-site renewable technology, energy efficiency and waste reduction – including working to eliminate single-use plastics – to help meet Takeda’s sustainability goals.

Prospective donors can make online appointments to visit the Tukwila center (5951 S 180th St, Ste 101, Tukwila, WA 98188), which opens on Saturday, August 21. Individuals who choose to donate must pass a physical examination at their first visit and are screened at each visit to ensure they meet eligibility criteria. All donors are compensated for their time and commitment.

To learn more about BioLife Plasma Services, the donation process and to schedule an appointment, please visit the BioLife website. Learn more about Takeda’s commitment to environmental sustainability on the company’s website.

About BioLife Plasma Services

BioLife Plasma Services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies. Founded in 2002, BioLife has been in operation for 18 years. We operate more than 180 state-of-the-art plasma collection facilities across the United States and Europe. BioLife Plasma Services is part of Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), a global values-based, R&D-driven pharmaceutical company that produces and delivers plasma-based therapies among other specialty medicines. For more information, visit BioLifePlasma.com.

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to discover and deliver life-transforming treatments, guided by our commitment to patients, our people and the planet. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Genetics and Hematology, Neuroscience, and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We are focusing on developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to improving quality of life for patients and to working with our partners in healthcare in approximately 80 countries and regions. For more information, visit https://www.takeda.com.

About Plasma

Plasma is the clear, straw-colored liquid portion of blood that can be easily replaced by the body. Plasma makes up more than half of whole blood and consists primarily of water and proteins. During plasma donation, a donor’s blood is collected into an automated device that separates the plasma from the other whole blood components, including red and white blood cells and platelets. While the plasma is collected, the other blood components are returned to the donor. Each donation procedure uses sterile and disposable collection materials. The body quickly replaces the plasma removed during the donation process, which allows healthy individuals to donate as often as twice in a seven-day period, with at least one day between donations.

Media:

Alicia Highlander

BioLife Plasma Services

[email protected]

Lauren Barbiero

Real Chemistry

(646) 564-2156

[email protected]

KEYWORDS: United States North America Washington

INDUSTRY KEYWORDS: Cardiology Biotechnology Pharmaceutical Environment Alternative Energy Health Energy Hospitals

MEDIA:

Logo
Logo

Baidu Announces Upgraded Baidu Brain 7.0 and Mass Production of 2nd Generation Kunlun AI Chip

New offerings shared at Baidu World 2021 set to widen access and application of AI technology

PR Newswire

BEIJING, Aug. 18, 2021 /PRNewswire/ — Baidu today showcased its strengths in artificial intelligence technology with the launch of Baidu Brain 7.0, the start of mass production of its 2nd generation Kunlun AI chip, Kunlun II, and the demonstration of industrial applications using Baidu AI Cloud. Shared at Baidu World 2021, Baidu’s annual flagship technology conference, the announcements represent the depth of Baidu’s expertise in AI technology and industrial practice, and its efforts to make AI technology more accessible.

“AI technology is growing increasingly complex, and integrated innovation has made AI more powerful,” said Haifeng Wang, Baidu’s Chief Technology Officer at Baidu World 2021. As AI technology plays an expanding role in a wider range of industries and drives a new era of technological revolution and industrial transformation, it is increasingly important to lower the threshold for different real-world applications and to increase accessibility to AI development platforms.

A key infrastructure supporting industrial applications of AI and Baidu Cloud, Baidu Brain is one of the world’s largest AI open platforms. The newly upgraded Baidu Brain 7.0 offers greater integration of a wide array of knowledge sources and deep learning, including language comprehension and reasoning, using numerous combined technologies to enable output across language, voice and visual formats. 

Working together with Baidu Brain 7.0’s software capabilities is the new Kunlun II AI Chip, providing an improved hardware foundation for a new generation of AI applications. Independently developed by Baidu, Kunlun II offers 2-3 times more processing power than the previous generation, using the world’s leading 7nm process and equipped with Baidu’s own second-generation XPU architecture.

The chip can be applied in multiple scenarios, including cloud, terminal, and edge, able to empower high-performance computer clusters, biocomputing and intelligent transportation and autonomous driving. Specifically optimized for AI technologies such as voice, natural language processing and images, the new Kunlun chip supports deep learning frameworks such as Baidu’s open source platform PaddlePaddle. This diverse range of uses gives the 2nd generation Kunlun AI Chip a powerful potential role in powering AI applications ranging from Internet core algorithms to smart cities and smart industry.

Both Baidu Brain 7.0 and Kunlun II allow for significantly enhanced accessibility and ease of use. Together with Baidu’s PaddlePaddle, the bundled AI platform offers a diverse product system to help different types of developers use AI technology quickly and efficiently, providing a wealth of tools to simplify the development and implementation of AI in real world scenarios.

To date, more than 3.6 million developers around the world have developed 400,000 AI models through PaddlePaddle, serving over 130,000 enterprises and institutions across a range of fields and industries. Applications have helped water management systems run more efficiently, helped improve quality control in manufacturing, and even helped athletes achieve greater precision in their training.

As part of Baidu’s efforts to increase the accessibility of AI technology, the company also announced the launch of Songguo Academy at Baidu World 2021. Providing a full set of educational resources, from long-term courses of study and training seminars to competitions, Songguo Academy draws on support from both the tech industry and academia to build a platform for training a new generation of AI professionals.

Baidu believes that the potential of AI is bright and limitless. Baidu Brain, the Kunlun II AI chip, PaddlePaddle and other software and hardware are a powerful combination delivering transformative AI technologies, which are set to serve us everywhere in the future. In this era of great change, Baidu is pursuing innovation AI applications that will benefit humanity and improves the lives of all in the future.

To see the recording of the conference with English translation, please visit: https://www.youtube.com/watch?v=oPjJqofYx7g

About Baidu

Founded in 2000, Baidu’s mission is to make the complicated world simpler through technology. Baidu is a leading AI company with strong Internet foundation. Baidu is traded on the NASDAQ Global Select Market under the symbol “BIDU”, and on the main board of the Hong Kong Stock Exchange under the stock code “9888”. Currently, one ADS represents eight Class A ordinary shares. 

Media Contact:[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/baidu-announces-upgraded-baidu-brain-7-0-and-mass-production-of-2nd-generation-kunlun-ai-chip-301358126.html

SOURCE Baidu, Inc.

Harris Williams Advises Myers Emergency Power Systems on its Sale to Kohlberg & Company, L.L.C.

Harris Williams Advises Myers Emergency Power Systems on its Sale to Kohlberg & Company, L.L.C.

RICHMOND, Va.–(BUSINESS WIRE)–Harris Williams, a global investment bank specializing in M&A advisory services, announces it advised Myers Emergency Power Systems (Myers EPS), a portfolio company of Graham Partners, on its sale to Kohlberg & Company, L.L.C. (Kohlberg). Myers EPS is a leading provider of mission-critical, legally mandated emergency power and smart controls technologies. The transaction was led by Eric Logue, Giles Tucker and Chris Toussaint of the Harris Williams Industrials Group and Michael Tuohey of the firm’s Richmond office.

“Myers EPS is a market leader providing differentiated technologies to highly attractive end markets. The management team has done a fantastic job driving product innovations that are shaping the future of their market,” said Eric Logue, a managing director at Harris Williams. “We are thrilled to have found Myers EPS a great partner in Kohlberg to continue executing on management’s vision.”

“It has been a privilege representing both Graham Partners and Myers EPS’ management team on this transaction, and we are excited to have delivered an extraordinary outcome for the company and its shareholders,” said Giles Tucker, a managing director at Harris Williams. “There continues to be significant interest in highly engineered, mission-critical industrial technology companies, and Myers EPS represents another marquee transaction for Harris Williams in the industrial technology sector.”

Myers EPS is a leading provider of highly engineered emergency backup power technologies serving a wide variety of growing and resilient industry segments, including data centers, warehouse and distribution centers, healthcare, education, and others. The company is a technology leader focused on developing innovative offerings that meet and surpass ever-changing industry demands and requirements, including smart IoT and sustainable offerings, delivering unparalleled ROI for customers. Headquartered in Bethlehem, Pennsylvania, Myers EPS employs over 160 employees across their Bethlehem, Pennsylvania and San Leandro, California facilities.

Graham Partners is a private investment firm focused on investing in technology-driven companies that are spurring innovation in advanced manufacturing, resulting in product substitutions, raw materials conversions and disruptions to traditional end markets. Graham Partners targets companies with EBITDA between $5 million and $50 million and will invest in smaller companies to the extent they complement one or more of its other holdings. Since the firm’s founding in 1988 by Steven Graham, Graham Partners has closed over 130 acquisitions, joint ventures, financings and divestitures. The committed capital raised since inception through the Graham Partners funds, together with Graham-led co-investments, totals approximately $3.4 billion, which differs from regulatory assets under management. Investors include university endowments, charitable foundations, financial institutions and private investors. Based in suburban Philadelphia, the firm has access to extensive operating resources and industrial expertise and is a member of The Graham Group, an alliance of independent operating businesses, investment firms and philanthropic entities, which all share in the common legacy of entrepreneur Donald Graham.

Kohlberg is a leading private equity firm headquartered in Mount Kisco, New York. Since its inception in 1987, Kohlberg has organized nine private equity funds, through which it has raised over $10 billion of committed equity capital. Over its 34-year history, Kohlberg has completed 85 platform investments and over 200 add-on acquisitions, with an aggregate transaction value of nearly $30 billion.

Harris Williams, an investment bank specializing in M&A advisory services, advocates for sellers and buyers of companies worldwide through critical milestones and provides thoughtful advice during the lives of their businesses. By collaborating as one firm across Industry Groups and geographies, the firm helps its clients achieve outcomes that support their objectives and strategically create value. Harris Williams is committed to execution excellence and to building enduring, valued relationships that are based on mutual trust. Harris Williams is a subsidiary of the PNC Financial Services Group, Inc. (NYSE: PNC).

The Harris Williams Industrials Group has experience across a variety of sectors, including advanced manufacturing; building products; chemicals and specialty materials; industrial technology; and packaging. For more information on the firm’s Industrials Group and other recent transactions, visit the Industrials Group’s section of the Harris Williams website.

Harris Williams LLC is a registered broker-dealer and member of FINRA and SIPC. Harris Williams & Co. Ltd is a private limited company incorporated under English law with its registered office at 8th Floor, 20 Farringdon Street, London EC4A 4AB, UK, registered with the Registrar of Companies for England and Wales (registration number 07078852). Harris Williams & Co. Ltd is authorized and regulated by the Financial Conduct Authority. Harris Williams & Co. Corporate Finance Advisors GmbH is registered in the commercial register of the local court of Frankfurt am Main, Germany, under HRB 107540. The registered address is Bockenheimer Landstrasse 33-35, 60325 Frankfurt am Main, Germany (email address: [email protected]). Geschäftsführer/Directors: Jeffery H. Perkins, Paul Poggi. (VAT No. DE321666994). Harris Williams is a trade name under which Harris Williams LLC, Harris Williams & Co. Ltd and Harris Williams & Co. Corporate Finance Advisors GmbH conduct business.

For media inquiries, please contact Julia Moore at [email protected].

Julia Moore

[email protected]

KEYWORDS: United States North America Virginia

INDUSTRY KEYWORDS: Banking Professional Services Finance

MEDIA:

Logo
Logo

Thinking about buying stock in Sesen Bio, NanoVibronix, Tencent Music Entertainment, New Oriental Education, or Ford Motor?

PR Newswire

NEW YORK, Aug. 18, 2021 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for SESN, NAOV, TME, EDU, and F.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver’s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock’s overall suitability for investment.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-sesen-bio-nanovibronix-tencent-music-entertainment-new-oriental-education-or-ford-motor-301358099.html

SOURCE InvestorsObserver

Thinking about buying stock in Virpax Pharmaceuticals, Powerbridge Technologies, Sundial Growers, ContextLogic, or Palantir Technologies?

PR Newswire

NEW YORK, Aug. 18, 2021 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for VRPX, PBTS, SNDL, WISH, and PLTR.

To see how InvestorsObserver’s proprietary scoring system rates these stocks, view the InvestorsObserver’s PriceWatch Alert by selecting the corresponding link.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

InvestorsObserver’s PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock’s overall suitability for investment.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-virpax-pharmaceuticals-powerbridge-technologies-sundial-growers-contextlogic-or-palantir-technologies-301358097.html

SOURCE InvestorsObserver

Thinking about trading options or stock in Apple, Moderna, Nio, Advanced Micro Devices, or Alibaba?

PR Newswire

NEW YORK, Aug. 18, 2021 /PRNewswire/ — InvestorsObserver issues critical PriceWatch Alerts for AAPL, MRNA, NIO, AMD, and BABA.

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report – Measures a stock’s suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street’s opinion including a 12-month price forecast.

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-apple-moderna-nio-advanced-micro-devices-or-alibaba-301358107.html

SOURCE InvestorsObserver

Picocom Accelerates 5G Communications SoC Development with Cadence Palladium Emulation

Picocom Accelerates 5G Communications SoC Development with Cadence Palladium Emulation

The Palladium Emulation Platform enabled Picocom to increase verification throughput and accelerate embedded software development.

SAN JOSE, Calif.–(BUSINESS WIRE)–
Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced that Picocom has deployed the Cadence® Palladium® Enterprise Emulation Platform to accelerate the verification and pre-silicon software validation of its system-on-chip (SoC) designs for 5G open radio access network (RAN)applications. Using the Palladium emulation platform, Picocom achieved faster hardware and software integration, experiencing an emulation speedup of 1000X when compared with RTL simulation.

The Palladium emulation platform gave Picocom the ability to bring up system software on RISC-V cores in advance of silicon being available. Using the Palladium emulation platform, Picocom took advantage of fast, predictable compile and was able to quickly debug its design. Picocom also met its power budget requirements using the Palladium Dynamic Power Analysis (DPA) feature, the Cadence Joules RTL Power Solution and the Cadence Voltus IC Power Integrity Solution to identify, capture and analyze power activity. To run efficient interface testing, Picocom utilized the Cadence SpeedBridge® adapters for PCI Express® (PCIe®) 4.0, USB 3.0 and Ethernet. Additionally, Picocom’s international team of engineers took advantage of the Palladium emulation platform’s remote accessibility, which allowed them to seamlessly work together to validate their designs.

“Developing 5G applications is extremely competitive, so we have to work at top speed while delivering the best products,” said Peter Claydon, President, Picocom. “We’re emulating a 5G NR RAN where the slot length is generally 0.5ms, and most of the time, we need to emulate a few slots, which Palladium emulation now enables us to do in a matter of minutes. The Cadence Palladium emulation platform has dramatically improved our team’s efficiency, and the investment proved to be well worth it.”

The Palladium Enterprise Emulation Platform is part of the Cadence Verification Suite and supports the company’s Intelligent System Design strategy, enabling SoC design excellence. The Cadence Verification Suite is comprised of core engines and verification fabric technologies that increase verification throughput and design quality, fulfilling verification requirements for a wide variety of applications and vertical segments. For more information on the Palladium emulation platform, please visit www.cadence.com/go/PalladiumSuccess.

About Cadence

Cadence is a pivotal leader in electronic design, building upon more than 30 years of computational software expertise. The company applies its underlying Intelligent System Design strategy to deliver software, hardware and IP that turn design concepts into reality. Cadence customers are the world’s most innovative companies, delivering extraordinary electronic products from chips to boards to systems for the most dynamic market applications, including consumer, hyperscale computing, 5G communications, automotive, mobile, aerospace, industrial and healthcare. For seven years in a row, Fortune magazine has named Cadence one of the 100 Best Companies to Work For. Learn more at cadence.com.

© 2021 Cadence Design Systems, Inc. All rights reserved worldwide. Cadence, the Cadence logo and the other Cadence marks found at www.cadence.com/go/trademarks are trademarks or registered trademarks of Cadence Design Systems, Inc. PCI Express and PCIe are registered trademarks of PCI-SIG.All other trademarks are the property of their respective owners.

Cadence Newsroom

408-944-7039

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Semiconductor Hardware Electronic Design Automation Technology Software

MEDIA:

Logo
Logo

Health Unveils Winners of the 2021 Sleep Awards

Second Annual Sleep Awards Showcase the 43 Latest and Greatest Innovations Designed for Your Best Night’s Sleep

PR Newswire

NEW YORK, Aug. 18, 2021 /PRNewswire/ — Meredith Corporation’s (NYSE: MDP) Health released the second annual edition of its Sleep Awards honoring the 43 top products for your best rest, spanning categories that include emerging tech, such as sleep trackers, audio devices, and snoring aids, plus comfort classics like mattresses, sheets, pillows, and more. In addition, Health editors and a panel of experts provide sought-after answers to questions about napping, snoring, sleep supplements, and more. The honorees are featured in the September 2021 issue on newsstands now, and the full list can be viewed online at Health.com.

“At Health, we believe good sleep equals good health. According to the American Academy of Sleep Medicine, more than half of Americans reported an increase in sleep problems since the start of the pandemic. Our Sleep Awards help people catch up on some much-needed rest, with all the best recommendations for a better sleep,” said Editor in Chief Amy Conway.

Health editors and a panel of experts sifted through hundreds of innovations to select this year’s top sleep products tailored to a variety of sleep styles and comfort requirements. Health’s Sleep Awards honor the latest and greatest technologies on the market that connect with your body’s sleep patterns, rhythm, and habits.

The September issue of Health is available on newsstands now and the full list can be read below and online at Health.com.


Health’s Sleep Awards

Mattresses:

  • Cooling: Tempur-LUXEbreeze°
  • Stomach Sleepers: Beautyrest Hybrid 12.5″
  • Back Sleepers: Saatva Classic Mattress
  • Pressure Relief: Avocado Green Mattress With Adjustable Bed Frame Base
  • Side Sleepers: Bedgear M3
  • Combo Sleepers: The Purple Mattress

Audio Devices:

  • Bose Sleepbuds II
  • Watotgafer Sleep Headphones/Mask
  • Snooz White Noise Sound Machine

Mattress Toppers:

  • Cooling: Ooler Sleep System
  • Cooling: Molecule AirTec Topper
  • Pressure Relief: Bamboo Talalay Latex Topper
  • Pressure Relief: Serta Calming 3″ Gel Memory Foam Mattress Topper

Sheets:

  • Cozy Earth Sheet Set
  • Sleep Number True Temp Sheets
  • Brooklinen Luxe Sateen Core Sheet Set
  • L.L. Bean Ultrasoft Comfort Flannel Sheet Set

Sleep Trackers:

  • Oura
  • Sleep Cycle
  • Withings Sleep Tracking Mat and Steel HR Hybrid Smartwatch
  • Biostrap Recover Set
  • Tempur-Ergo Smart Base powered by Sleeptracker-AI

Pillows:

  • Side Sleepers: Planet Pillow
  • Side Sleepers: Layla Sleep Kapok Pillow
  • Back Sleepers: Beautyrest Black Ice Memory Foam
  • Back Sleepers: Brooklinen Mid-Plush Down Pillow
  • Stomach Sleepers: Pluto Pillow
  • Stomach Sleepers: Healthy Sleep Therma-Tech Copper Pillow
  • Hypoallergenic: Everpillow
  • Body Pillow:Zoma Body Pillow

Snoring Aids:

  • Mute
  • SinuSonic
  • SnoreLab

Blankets & Comforters:

  • Coyuchi Tahoe Climate Beneficial Wool Blanket
  • Sheex Original Performance Down Alternative Comforter
  • ChiliBlanket
  • Bedgear Dri-Tec Medium Warmth Climacore Blanket
  • Baloo Weighted Blanket

Emerging Tech:

  • Wesper Sleep Kit
  • Somnox Sleep Robot
  • Google Nest Hub With Sleep Sensing
  • Somnofy Sleep Assistant
  • Sleep Care Online Home Apnea Test

The panel of experts that were chosen to create this year’s list included: Michael J. Breus, PhD, clinical psychologist, diplomate of the American Board of Sleep Medicine, and fellow of the American Academy of Sleep Medicine; Elise Chahine, editor-in-chief of SleepFoundation.org; Vivek Cherian, MD, doctor of internal medicine at the University of Maryland; Param Dedhia, MD, director of executive health and integrative medicine at Moveo Health and former director of sleep medicine for Canyon Ranch; Marci Hardy, MD, health educator and sleep expert; Angela Holliday-Bell, MD, certified sleep specialist and pediatrician in Arlington, Virginia; Mollie McGlocklin, creator of the company Sleep Is a Skill; W. Chris Winter, MD, neurologist and sleep expert based in Charlottesville, Virginia, and Health Advisory Board member; and Jade Wu, PhD, board-certified behavioral sleep medicine specialist and researcher at the Duke University School of Medicine.

ABOUT HEALTH

Health is the trusted source for all things relating to wellness. Offering solid, science-backed advice on physical and mental health, exercise, skin care and beauty, nutrition, and much more, Health empowers its wide, multi-generational audience of more than 18 million across platforms. Additional information can be found at Health.com.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/health-unveils-winners-of-the-2021-sleep-awards-301358108.html

SOURCE Meredith Corporation